Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications

Table 2 Liver steatosis in patients with coronavirus disease 2019 infection, n (%)

Ref.	Histological findings	Present
Lagana et al[28]	Macrovesicular steatosis	30/40 (75)
Sonzogni et al[45]	Steatosis	26/48 (54)
Chu et al[32]	Microvesicular steatosis	20/24 (83)
	Macrovesicular steatosis	5/24 (21)
Vishwajeet et al[44]	Macrovesicular steatosis	18/20 (90)
Duarte-Neto et al[51]	Steatohepatitis	3/75 (4)
	Steatosis	42/75 (56)
Schmit et al[43]	Steatosis	9/13 (69)
Sweed et al[33]	Macrovesicular steatosis	1/1 (100)
Santana et al[49]	Steatosis	17/27 (63)
Yurdaisik et al[48]	Macrovesicular steatosis	4/7 (57)
Canillas et al[52]	Steatohepatitis	10/14 (71)
	Steatosis	1/14 (7)
Ramos-Rincon et al[47]	Steatosis	12/39 (31)
Pesti et al[29]	Steatosis	93/147 (63)

Some authors refer to the severity of steatosis as mild < 10% or severe > 10%, and others as macrovesicular or microvesicular steatosis.